CDK2 and glioblastoma: To validate the interaction modification of FOXO1 and CDK2 in GBM cells, endogenous FOXO1 proteins were subjected to IP assay with FOXO1 antibody and immunoblotted with ubiquitin and CDK2 antibodies.